Drag to reposition cover
https://www.selleckchem.com/products/cc-115.html
Selective androgen receptor modulators (SARMs), because of their preferential muscle vs prostate selectivity, are being developed for muscle-wasting conditions. Oral SARMs suppress high-density lipoprotein cholesterol (HDL-C) but their effects on functional capacity and atherogenic potential of HDL particles are unknown. To determine the effects of an oral SARM (OPK-88004) on cholesterol efflux capacity, HDL particle number and size, apolipoprotein particle number and size and HDL subspecies. We measured cholesterol efflux capacity (CEC)
Like
Comment
Share
Load more posts
Likes
(14)
Crop your avatar
